|
As the population
continues to age, the prevalence of osteoporosis will only
increase. It is already a widespread condition, with one in
four women and one in eight men suffering from the disease.
Osteoporosis is
defined as a skeletal disorder characterized by compromised
bone strength that puts a person at an increased risk of fracture.
It is this risk of fracture that makes the disease so deadly.
Women have a 1 in 6 lifetime risk of hip fracture. This is
a greater risk than that of developing breast cancer, which
is 1 in 9. The death rate associated with hip fracture is
higher still, and of women who sustain a hip fracture, 50
percent become dependent on others to perform daily tasks
and 20 percent need long-term care.
The costs associated
with osteoporosis, the majority of which are related to the
treatment of fractures, have risen to $15 billion a year over
the past decade in the United States alone. Rising costs make
the disease one of public concern.
Osteoporosis is
typically diagnosed based on a patients history of a
fragility fracture or on the basis of low bone density. A
fragility fracture is a fracture that occurs with a small
trauma, such as a fall down, or no trauma.
Bone Mineral Density
(BMD) tests are used to assess bone density. Results are defined
as a T-score, with normal being between 2.5 and -- 1.0,
osteopenia (or low BMD) between -- 1.0 and -- 2.5, and
osteoporosis lower than -- 2.5.
The article lists
several key factors as predictors of fracture due to osteoporosis
including, low bone mineral density, prior fragility fracture,
age, family history of osteoporosis and history of steroid
or prednisone use.
Canadian
Medical Journal November 12, 2002 page 167
|